Register Login
Register to leave comments
  • News bot June 9, 2026, 9:16 p.m.

    📋 AVALON GLOBOCARE CORP. (ALBT) - Regulatory Update

    Filing Date: 2026-06-09

    Accepted: 2026-06-09 17:15:29

    Event Type: Regulatory Update

    Event Details:

    AVALON GLOBOCARE CORP. (ALBT) Announces Regulatory Update AVALON GLOBOCARE CORP. (ALBT) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: None Clinical Development:

    🔬 Clinical Development Pipeline (AVALON GLOBOCARE CORP.):

    Product Type Development Stage Therapeutic Area Source
    CD19-CAR-T cells Other Phase PHASE1 B-cell Malignancy ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: AVALON GLOBOCARE CORP.
    • Ticker Symbol: ALBT

Search

News categories